An Introduction to Double Dragon Consulting

Similar documents
Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Regulatory Affairs, Compliance Assurance, Quality Systems, Remediation Strategy and Support, and Strategic Consulting Services

Robbie Morehead Project Manager

INVESTIGATIONS BOOTCAMP NIBRT (NATIONAL INSTITUTE FOR BIO-PROCESSING RESEARCH AND TRAINING)

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Staff Augmentation

GMP In-house Training

GxP Auditing, Remediation, and Staff Augmentation

Conducting Supplier Audits: Ensure Validation Compliance

PRAXIS. A publication by Bioengineering AG

EU and FDA GMP Regulations: Overview and Comparison

MEASURE FOR MEASURE: QUALITY METRICS

WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND

KINGSMANN CARE GROUP

Developing a Robust Quality System to Assure Data Integrity

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Inspections, Compliance, Enforcement, and Criminal Investigations

Responding to an FDA 483

a n d B i o s a fety C o n s i d e ra t i o n s

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals


Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Isolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite

UNICEF Quality Assurance in the procurement of medicines

Global experts in Remediation, Auditing, GMP Compliance, Education and Regulatory Affairs for the Pharma and Biotech Industry

GMP On Site Series. GMP Essentials

IPA Quality Forum Reflections on the Journey so far

OECD and EPA GLP Differences

OOS: Back to Basics. Compliant, Effective, Efficient PATH

Compounding Pharmacies and the Contract Testing Lab

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

Process Validation for Active Pharmaceutical Ingredients (API)

COMMERCIAL PRODUCT STABILITY

GMP for Medical Devices

Combination Products Part 4 Compliance and Implementation at multi-site Network

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Request for Quote RFQ #

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S)

Filling and Packaging Validation for FDA Regulated Industries

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Christian Gausepohl, Frank Böttcher. GMP Focus. Managing Contract Manufacturers and Testing Labs. PDF Download. Excerpt from the GMP MANUAL

By Dr. Michael Hiob, Max Lazar, Dr. Christian Gausepohl and Dr. Christine Oechslein. Preparing for the EU GMP Inspection

Basic Good Laboratory Practice. Christopher Jerome, B.Vet.Med., Ph.D

Isolator Technology Workshop Engineering - Validation - Operation

OPERON STRATEGIST. Technical Consulting & Regulatory Advisory Services. Mobile:

Drug Development Services

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

HEADQUARTERS SPAIN SPAIN (LIFT)

Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC

ASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01

Strategies for Risk Based Validation of Laboratory Systems

Current Trends in Sterile Manufacturing. by Sterling Kline, RA Director of Project Development Integrated Project Services (IPS)

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

Reference Standard Characterization. Steve Lane. General Manager, NSF Reference Standards.

Role of USP Monographs and. General Chapters. Steve Zigler, Ph.D.

Ampio Pharmaceuticals Production and Office Facility Englewood, Colorado

Industry Perspective on Manufacturing in Early Development

Questionnaire Layout:

WHO Prequalification of In Vitro Diagnostics Programme

GMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel

Overview of Good Food Laboratory Practices

for IND and RDRC Regulated PET Compounding

Vendor Qualification Survey

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

General Requirements for the Competence of Testing and Calibration Laboratories

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

Julie Roberts. Audit hot Topics and Regulatory Requirements

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

Supplier Assurance Program. CBE Pty Ltd

Regulatory Considerations and Trends Europe and the U.S.

Guidelines for Process Validation of Pharmaceutical Dosage Forms

CERTIFICATE IN BIOPHARMACEUTICALS

WHO Prequalification Team (WHO-PQT) Introduction to medicines inspections technical updates

GCP Basics - refresher

GMPs: Distribution Centers

CGMP for Phase 1 INDs

PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY

Standard operating procedures revisited: a 2014 perspective

MINIMUM REQUIREMENTS FOR A VENDOR

Training manual: licensing, lot release, laboratory access

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

EFFECTIVE CLINICAL TRIALS. NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program. Copyright 2014 NUSAGE-PharmEng.

Advanced Concepts for Change Control of Analytical Procedures with ICH Q12 Coming

Global Clinical Trials in Korea

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART 1

Implementation of 2005 Pharmaceutical Affairs Law and ICH Q8-Q10 in Japan

Quality Agreements and Managing Contract Supplier Quality

GMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM

Holding Your Suppliers Accountable

ICH Q3D Guideline Impact on the Users: Perspective of a Finished Product Manufacturer John Glennon

PMDA Perspectives Yoshihiro Matsuda, Ph.D.

Audits and Inspections

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

Stephanie Gentilin, CCRA

Challenges and Opportunities in the Development of integrated Drug Device Combination Products CMC Strategy Forum, Tokyo, 5 December 2017

Transcription:

An Introduction to Double Dragon Consulting www.doubledragonconsulting.com 1 June 2012

About DDC Our Experience: All dosage forms, aseptic processes, OTC Remediation of 483 observations, warning letters, consent decrees All phases of operation from construction, commissioning, and maintenance of aseptic processing facilities International (US, EU, Asia) Our Offices Headquarters in North Carolina Representative Office in Shanghai, PRC Our Associates Global network of experienced independent consultants 2

Clients Novartis Vaccines (US, EU, China) Novartis Pharma Novartis Consumer Health GSK Schering Plough Sandoz (EU) Genentech Hospira URL Mutual Washington Homeopathic Products Teva Forest Research Institute MedImmune Sanofi Pasteur Merck Cardinal Health Bayer Hoffmann LaRoche Steifel NuPathe ClinAudits Marianna Vertellus CibaVision 3

DDC Principal Stephen Sheng, MSQA Principal Double Dragon Consulting MS Quality Assurance, BS Biochemistry ASQ Certified Quality Auditor and Certified Quality Engineer 24+ years of Pharma experience Wide Range of experience: OSD, Injectables, Vaccines, Medical Devices, APIs, and Dietary Supplements 483, Warning Letter, and Consent Decree Remediation Investigations and CAPAs Aseptic Operator Training Supply Chain and Supplier Qualification Customer complaints Annual Product Reviews Audits for ISO 13485, MDD, and CE Marking Project Management 4

DDC Principal George S. Bernstein, Ph.D. Principal Double Dragon Consulting Ph.D. in Chemical Engineering 25+ years of Pharma experience Wide range of experience: Quality Systems Development, Remediation, FDA communications GMP, GCP, GLP, GPP Quality Guidelines Operational Excellence Training Project/Program Management Facility Construction and Commissioning Investigations / Root Cause Analysis Business Process Re-engineering 5

Our Philosophy Experienced Professionals We provide consultants with the right expertise and experience from our global network to meet your needs subject to your review and approval Flexibility: Work can be performed on site or remotely via Internet Sustainability Our goal is to transfer our knowledge to your company so that together we achieve a sustainable solution 6

DDC Capabilities Quality and Validation support Training Regulatory Engineering Project Management Technical analytical method development 7

DDC Capabilities Quality and Validation Support Lead all aspects of compliance remediation activities Conduct deviation / product or lab failure investigations Evaluate / develop procedures, processes, and documentation to meet US and EU requirements Prepare Validation Master Plan Prepare / evaluate / execute validation protocols (process, equipment, cleaning, analytical methods, etc.) Third Party independent review of deviation, change control, and validation reports Evaluate change control, deviation, and validation reports Conduct audits / compliance gap assessments 8

DDC Capabilities Training Aseptic Operations including Gowning Qualification Deviation Management, Root Cause Analysis, CAPAs Internal Audits GMP regulations (US, EU, China) Technical Writing 9

DDC Capabilities Regulatory Prepare / review regulatory (IND, NDA, ANDA) submissions Prepare / review CMC sections of regulatory submissions Perform risk assessment and crisis management Perform mock Pre-Approval Inspection (PAI) Establish PAI action plan and execute remediation activities 10

DDC Capabilities Engineering Prepare conceptual designs / review designs for pharmaceutical manufacturing facilities, to include personnel and materials flows, facility layouts and manufacturing processes, HVAC system, utilities, automation system Provide expert guidance on Class A/B Cleanroom design to meet US, EU, and China requirements Provide guidance on Equipment Qualification and Commissioning Establish routine / preventive maintenance programs 11

DDC Capabilities Project Management Develop Project Plan with milestones, timelines and resources Establish and run a project management office (PMO) Establish / maintain work stream status reporting and tracking system Marketing Provide guidance or assist in product launch in China Identify qualified contract manufacturer in China Search for in-license/out-license opportunities in China 12

Projects Experience 1 Novartis Vaccines & Diagnostics Location: China Year: 2010-2011 Work Scope: Aseptic Operations, Supply Chain, Technical Transfer, and Engineering projects (bulk, fill/finish, QC). Deliverables/Outputs: Successfully led remediation projects for bulk, fill/finish, packaging, warehouse, and QC Lab areas including construction, equipment selection and procurement, commissioning and qualification, and process validation. Established training materials and provided training to hundred of employees on aseptic processing and techniques including gowning qualification and environmental monitoring. Recommended the selection of aseptic filling lines and critical equipment. Completed installation, commissioning, qualification and validation, which covers syringe filler, vial filler, aseptic filling suite, QC sampling suite, packaging area, & critical utility systems. Successfully supported the daily functions within Engineering and Supply Chain departments. 13

Projects Experience 2 Training Projects (Merck, Sanofi, Sandoz) Location: US, EU Year: 2010-2011 Work Scope: Aseptic Operations, formulation, bulk, fill/finish, QC, warehouse). Deliverables/Outputs: Led project to evaluate compliance risk and to recommend improvements to training organization, training processes, and training effectiveness. Led effort to evaluate/develop training materials for Operations, Deviation Management, and shop floor Quality Assurance departments. Acting as interim head of training for parenterals company to ensure training compliance and to improve the effectiveness of training materials. 14

Projects Experience 3 Compliance/Remediation Projects (Hospira, Sandoz, WHP, CibaVision) Location: US, EU Year: 2010-2011 Work Scope: Aseptic Operations, QA, Deviations Management. Deliverables/Outputs: Acted as 3rd party reviewer of parenteral manufacturer s deviation investigations, performed as a part of company s warning letter remediation. Role included coaching and mentoring. Led QC lab compliance remediation effort for a medical device manufacturer. Project included QC audits and project plan development. Led warning letter remediation project for small OTC manufacturer. Project involved training, documentation redesign, cleaning validation studies and direct interaction with the company owners and FDA. Prepared response letter and periodic updates to US FDA following receipt of 483 observations. 15

Projects Experience 4 Novartis Vaccines & Diagnostics Location: EU Year: 2009-2010 Work Scope: Deviations Management and Training Deliverables/Outputs: Reviewed hundred of deviation reports for adequacy, completeness, and GMP compliance. Developed and implemented qualification and mentoring programs for investigators and QA reviewers. Mentored and qualified 50+ investigators and QA reviewers. Established training materials and provided training to hundred of employees on investigations, root cause analysis, and CAPAs. Company successfully passed 2 FDA inspections. 16

Projects Experience 5 Sanofi Pasteur Location: US Year: 2008 Work Scope: Aseptic Operations (validation, bulk, fill/finish, QC). Deliverables/Outputs: Validation of vaccine facility developed Basis of Design documentation for sterile syringe filling facility that utilized high speed syringe filler with Restricted Access Barrier System (RABS) or Isolator technology. Developed process flow diagrams for new manufacturing processes which were used to evaluate process robustness and SOPs. Developed sample coordination process to ensure that all samples collected for cleaning, process, and equipment validation were accounted for. 17

Projects Experience 6 GSK Location: Puerto Rico Year: 2005-2007 Work Scope: Consent Decree (CD) Project. Deliverables/Outputs: Performed third party certification of all manufacturing deviations, OOS investigations, and customer complaints. Reviewed and certified 1000+ investigation reports for adequacy and GMP compliance. Established and implemented a tracking system for all deviations reviewed. Provided quarterly updates to FDA. Mentored all investigators and QA reviewers. Company successfully passed FDA inspection and released from CD. 18

Projects Experience 7 Schering Plough Location: Puerto Rico Year: 2002-2004 Work Scope: Consent Decree Project. Deliverables/Outputs: Successfully led a team to investigate and close 100+ manufacturing deviations. Successfully led Deviation Management System remediation projects including the re-design of the TrackWise system. Performed in-depth organizational assessment of entire site s ability to manage deviations (investigations and CAPAs). Established training materials and provided technical writing training to hundreds of employees. (Company successfully passed FDA inspection and released from CD.) 19

Summary Efficiency We employ a Right First Time approach We will delivery your project on time and within budget Quality We will focus on knowledge transfer to your people Together, we will build a sustainable Quality System Compliance We have the knowledge of US, EU and China GMP requirements We have the technical expertise in all dosage forms We will help you get there and stay there LET US PUT OUR TEAM TO WORK FOR YOU 20

Contact Information Phone US: +1 (919) 434-3005 or +1 (626) 641-0961 China: +86-021-6275-7333 Email Info@DoubleDragonConsulting.com Website www.doubledragonconsulting.com 21